Sign inJoin waitlistJoin the waitlist

Mehrdad Abedi

Hematology & Oncology · Regents of the Univ of Ca

Credentials: · · ·

History

Brown University, Roger Williams Medical Center
2001–2002
University of Massachusetts Medical Center
1999–2001
Yale University/Bridgeport Hospital
1996–1999
Yale University/Bridgeport Hospital
Until 1999
Tehran University of Medical Sciences
1991

Research

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
The Lancet · 2021 · 704 citations
Advances in graft-versus-host disease biology and therapy
Nature reviews. Immunology · 2012 · Last of 3 authors · 692 citations
Participation of bone marrow derived cells in cutaneous wound healing
Journal of Cellular Physiology · 2003 · 315 citations

Peter Quesenberry
25 papers
GC
Gerald Colvin
23 papers
Joseph Tuscano
13 papers
Rasmus Hoeg
12 papers
Brian Jonas
10 papers
Aaron Rosenberg
9 papers
Aaron Logan
8 papers
Daniel DeAngelo
8 papers
JP
Jae Park
8 papers
Michael Bishop
8 papers
BS
Bijal Shah
7 papers
Mingyi Chen
7 papers

Grants

New Approaches to Tissue Repair
National Center for Research Resources · P20
Project lead · $1.9M · Roger Williams Hospital
2004–2011
Cell Cycle Related Transdifferentation Plasticity
National Heart, Lung, and Blood Institute · K08
Contact PI · $606.4K · Roger Williams Hospital
2003–2008

Clinical trials

Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma
Principal investigator · Not yet recruiting · Phase 1
University of California, Davis
2026–2033
Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Principal investigator · Recruiting · Phase 1
University of California, Davis
2021–2027
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
Principal investigator · Active not recruiting · Phase 1, Phase 2
AIDS Malignancy Consortium
2016–2036
Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma
Principal investigator · Completed · Phase 1
Mehrdad Abedi, MD
2015–2018